Novo Eyes Global-First Japan Approval For Concizumab

First Filing For Hemophila A/B Candidate

 
• By Lisa Takagi
Concizumab can provide a new option for hemophilia A and B, Novo Nordisk says
Pen-Shaped Injector One Differentiator For Concizumab? • Source: Shutterstock

More from Japan

More from Focus On Asia